NCT06966427 - Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

May 25, 2026

Study Completion Date

May 25, 2026

Conditions

Type 1 DiabetesType 2 Diabetes

Interventions

DEVICE

Dosing Guidance System to be used with both time and amount of insulin as input

Any insulin dosing event manually logged by the participant, the DGS will receive the time and amount of the dose as input

DEVICE

Dosing Guidance System to be used with only time of insulin as input

any insulin dosing event manually logged by the participant, the DGS will receive only the time of the dose as input

Trial Locations (2)

NOT_YET_RECRUITING

Schneider Children Medical Center of Israel, Petah Tikva

RECRUITING

University Medical Center of Ljubljana, Ljubljana